11 Best Performing Healthcare Stocks to Buy Now

Page 2 of 10

9. Option Care Health, Inc. (NASDAQ:OPCH)

YTD Performance: 37.24%

Number of Hedge Fund Holders: 40

Option Care Health, Inc. (NASDAQ:OPCH) provides infusion therapy and similar ancillary healthcare services through a national network of full-service pharmacies. It holds contracts with hospitals, physicians, third-party payers, managed care organizations, and other referral sources to provide complex compounded solutions and pharmaceuticals to patients. The company’s home infusion services include bleeding disorder therapies, nutrition support, anti-infectives, and more.

On April 30, UBS analyst A.J. Rice upgraded the rating on Option Care Health, Inc. (NASDAQ:OPCH) to a Buy and set a price target of $40.00, highlighting the company’s strategic positioning and strong financial performance. The company’s fiscal Q1 2025 financials also reflected a robust earnings momentum.

Effective inventory management supports the analyst’s belief that the impact of STELARA, a prescription drug that treats moderate to severe plaque psoriasis, will be less severe than expected. STELARA’s integration in Option Care Health, Inc.’s (NASDAQ:OPCH) earnings is anticipated to support long-term growth. This is especially true as the healthcare industry shifts care from institutional settings to home, which is proving beneficial to Option Care Health, Inc.’s (NASDAQ:OPCH) diversified drug portfolio.

The analyst also reasoned that the company’s solid free cash generation ability and balance sheet position it well for strategic acquisitions in a fragmented market, supporting the buy rating. The company is also well-positioned to manage potential tariff impacts through its inventory management, strategic contracts, and risk mitigation related to cost inflation.

Page 2 of 10